Posters

2009:
This poster was presented at the 1th annual Journal of Cell Biology
Meeting, “Cell Biology of Disease: Chromosomes, Cancer and Stem Cells” at
the New York Academy of Science, New York, USA, september 2009 and at the
the 15th annual cancer symposium of the Danish Cancer Society, “Genetic
Instability and Stem Cancer Cells”, Copenhagen, Denmark, oktober 2009 by
Karina Kristoffersen, Research Assistant at Department of Radiation
Biology. Brain cancer stem-like cells show sensitivity towards Notch inhibition. (click here to view poster in pdf format)

SNOG poster from Helsinki, by Benedikte Hasselbalch (click here to view poster in pdf format)

SNO poster from New Orleans, by Benedikte Hasselbalch (click here to view poster in pdf format)

This poster was presented October 2009 at the SNO 2009 Meeting in New Orleans, by Kenneth Hofland. Title of presentation: First-line therapy with Bevacizumab and Irinotecan versus Bevacizumab and Temozolomide and Delayed Concomitant Radiotherapy in Newly Diagnosed Primary Glioblastoma Multiforme: Early Results From a Randomized Phase II Study.
(click here to view poster in pdf format)

Prognostic and predictive value of MGMT evaluated by immunohistochemistry in a series of glioblastoma multiforme.(click here to view poster in pdf format)

SNOG poster from Helsinki 2009.(click here to view poster in pdf format)

This poster was presented at the 4th Danish Conference on
Biotechnology and Molecular Biology; Biomarker discovery and drug
development in the omics era in Vejle, Denmark in May 2009 by Torben
Gjetting, Research Scientist at Department of Radiation Biology:
In vivo delivery of transcriptionally targeted gene therapy of small cell lung carcinoma. (click here to view poster in pdf format)

This poster was presented at American Society of Gene Therapy (ASGT),
Annual Meeting in San Diego, USA, in May 2009 by Frederik Cramer, Research
Assistant at Department of Radiation Biology.
Optimization of non-viral gene delivery to the nucleus for small cell lung
cancer gene therapy. (click here to view poster in pdf format)

This poster was presented at American Society of Gene Therapy
(ASGT), Annual Meeting in San Diego, USA, in Maj 2009 by Camilla Laulund Christensen, Ph.d. student at Department of Radiation Biology.
The suicide fusion gene YCD-YUPRT induces high and specific cytotoxicity in small cell lung cancer cell lines and tumor growth delay in xenografts when regulated from a cancer-specific promoter.
(click here to view poster in pdf format)

This poster was presented at American Association for Cancer Research
(AACR), Annual Meeting 2009 in Denver, USA, in April 2009 by Alice
Bjerregaard Larsen, Phd-student at Department of Radiation Biology.
Activated EGFR induce trans-phosphorylation of EphA2 in cancer cells.
(click here to view poster in pdf-format)

2008:
Poster presentation at the Society for Neuro-Oncology (SNO) Scientific
Annual meeting in Las Vegas, USA, in november 2008. Presented by Benedikte
Hasselbalch M.D and PhD student at Department of Radiation Biology. The poster shows the mature data from the clinical phase II protocol investigating the effect of
the EGFR inhibitor cetuximab (Erbitux) in combination with the VEGFR
inhibitor bevacizumab (Avastin) and Irinitecan.
(click here to view poster in pdf-format)

This poster will be presented by Chief Physician, Ulrik Lassen, MD, Ph.D, at the American Society for Clinical Oncology Yearly meeting in Chicago, June, 2008. It represents the first results ever published of this combination in patients with Glioblastoma Multiforme. The patients were treated with Cetuximab - a EGFR inhibitor -, Avastin - a VEGFR inhibitor - and Irenotecan. (click here to view poster in pdf-format)

The function of normal and mutated epidermal growth factor receptors in Glioblastoma Multiforme - Establishment of an in vivo and in vitro model. (click here to view poster in pdf-format)

A chimeric fusion of the human Achaete Scute Homolog 1 and Enhancer of Zeste Homolog 2 promoters is a promising regulator of suicide gene therapy for small cell lung cancer. (click here to view poster in pdf-format)

Identification of tumour-suppressor-gene candidates in small cell lung cancer, which alone or combined with a p53-reactivating molecule, can be used for cancer gene therapy. (click here to view poster in pdf-format)

Potential of therapeutic genes for small cell lung cancer gene therapy. (click here to view poster in pdf-format)

2007:
Transcriptionally targeted cancer gene therapy for small cell lung cancer. (click here to view poster in pdf-format)

The role of EphA2 in EGF-induced cancer cell proliferation and motility. (click here to view poster in pdf-format)

The function of normal and mutated epidermal growth factor receptors in Glioblastoma Multiforme - Establishment of an in vivo model. (click here to view poster in pdf-format)

Improved response by co-targeting EGFR/EGFRvIII and c-Src. (click here to view poster in pdf-format)

EGFR induces expression of IRF-1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells. (click here to view poster in pdf-format)

Identification of novel tumor suppressor genes specific for small cell lung cancer and primary glioblastoma multiforme. (click here to view poster in pdf-format)